Research and Clinical Trials

HIV Treatment Experienced Attachment Inhibitor Study
Brief Description  
The purpose of this study is to determine if an investigational treatment regimen of BMS-663068 (BMS Attachment Inhibitor) twice a day, plus other antiretroviral medications used in combination is safe and effective for the treatment of subjects who are infected with Human Immunodeficiency Virus (HIV-1). HIV positive subjects in this research study must be "Heavily Treatment Experienced". This means you must have taken many HIV medications during the history of your disease.
Who may be Eligible  
Adult patients with HIV who are failing their current regimen and have less than or equal to 2 classes of medications available to them; Participants must agree to protocol defined birth control methods during the study; Subjects will need to have normal maintenance labs and EKG resutls as defined by the study parameters.
Start Date  
IRB Number  
Principal Investigator  
Johnson, Marc
Contact Name  

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (704) 446-7641 
Address:  1350 South Kings Drive, 3rd Floor
Myers Park Clinic
Charlotte, NC 28207